Excipients are an integral part of any pill, and they are becoming more complex with time. The complexity plays a significant role from the regulatory aspect and their role in the drug’s function.
In this podcast episode, our guest is Philippe Tschopp. Philippe is a Business Developer at Glatt Pharma and an enormous Excipient enthusiast. Because of his passion, he founded the website www.pharmaexcipients.com, where they post scientific insights about developments in the excipient world.
In this episode, Yan Kugel interviewed Philippe about the ever-changing excipient landscape and their role in drug manufacturing.
Listing to the podcast, or watching the video, among others, you will learn about:
What makes excipients such an exciting field
How pharmaexcipients.com was born, and what is its purpose?
Where is the excipient market heading?
What should change in the excipient world?
What can be achieved by choosing the most optimal excipient for the novel drug?
This episode is Sponsored by Dot Compliance, the industry’s first ready to use Quality Management Solution powered by the SalesForce platform. Implementation of a new eQMS has never been quicker nor easier.
Information on good manufacturing practices (GMP) in the life science industry is scattered, vague and poorly organized. We have chosen to solve this problem by organizing the best possible GMP webinars and courses to ensure we deliver all the information you need in a concise, engaging and clear format. All events are free and open to anyone in the industry.
Philippe is the head of business development at Glatt Pharmaceutical Services. He has solid experience of well over a decade in sales, B2B digital marketing, and networking in the pharma industry and is enthusiastic about excipients and solid dosage forms.